Substantia Nigra Dopamine Neurons In Aceruloplasminemia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dopaminergic neurons in the substantia nigra are affected in aceruloplasminemia.
| Property |
Value |
| Category |
Basal Ganglia |
| Location |
Substantia nigra pars compacta |
| Cell Type |
Dopaminergic neurons |
| Neurotransmitter |
Dopamine |
- Motor Control: Movement initiation and regulation
- Reward Processing: Motivation and reinforcement
- Cognition: Executive function
- Sleep-Wake Cycle: Arousal regulation
- CP gene mutation: Ceruloplasmin deficiency
- Systemic iron accumulation: Liver, brain, retina
- Ferritin elevation: Iron storage protein
- Free radical damage: Oxidative stress
- Dopaminergic loss: Motor symptoms
- Astrocytic iron: Ruby-red retina
- Cerebellar ataxia: Movement disorders
- Cognitive decline: Dementia development
- Movement disorders: Tremor, dystonia
- Ataxia: Coordination problems
- Anemia: Microcytic iron deficiency
- Retinal degeneration: Vision loss
- Iron chelation: Deferoxamine therapy
- Plasma infusions: Ceruloplasmin replacement
- Antioxidants: Coenzyme Q10
- Symptomatic treatment: Movement management
The study of Substantia Nigra Dopamine Neurons In Aceruloplasminemia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Miyajima H. Aceruloplasminemia. Brain Dev. 2003.
- Kono S. Aceruloplasminemia: review. Rinsho Shinkeigaku. 2004.